|
|
|
16.06.25 - 22:09
|
Streamline Health® Reports Fiscal First Quarter 2025 Financial Results (GlobeNewswire EN)
|
|
|
ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fiscal first quarter of 2025 which ended April 30, 2025....
|
|
|
|
|
|
|
|
|
16.12.24 - 22:36
|
Streamline Health® Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline (GlobeNewswire EN)
|
|
|
ATLANTA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the third quarter of fiscal 2024, which was the three-month period ended October 31, 2024, and the nine-month period ended October 31, 2024....
|
|
|
09.12.24 - 23:18
|
Streamline Health® To Report Fiscal Third Quarter 2024 Financial Performance (GlobeNewswire EN)
|
|
|
ATLANTA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three month period ended October 31, 2024 on Monday December 16, 2024 after the close of the financial markets....
|
|
|
04.10.24 - 08:43
|
XFRA : LV10: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
STREAMLINE HEALTH SOL.NEW LV10 US86323X2053 BAW/UFN...
|
|
|
|
|
03.10.24 - 23:43
|
XFRA : NEW INSTRUMENT AVAILABLE - 04.10.2024 - US86323X2053 (XETRA)
|
|
|
Das Instrument LV10 US86323X2053 STREAMLINE HEALTH SOL.NEW EQUITY hat seinen ersten Handelstag am 04.10.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N
The instrument LV10 US86323X2053 STREAMLINE HEALTH SOL.NEW EQUITY has its first trading date on 04.10.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...
|
|
|
03.10.24 - 16:40
|
XFRA : ISIN Change (XETRA)
|
|
|
Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
CA3874371147 Granite REIT LP 03.10.2024 CA3874372053 Granite REIT LP 04.10.2024 Tausch 1:1
US86323X1063 Streamline Health Solutions Inc. 03.10.2024 US86323X2053 Streamline Health Solutions Inc. 04.10.2024 Tausch 15:1
US59564R7089 Biodexa Pharmaceuticals PLC 03.10.2024 US59564R8079 Biodexa Pharmaceuticals PLC 04.10.2024 Tausch 25:1
KYG9845F1090 LakeShore Biopharma Co. Ltd. 03.10.2024 KYG9845F2080 LakeShore Biopharma Co. Ltd. 04.10.2024 Tausch 10:1
US82655M1071 Sify Technologies Ltd. 03.10.2024 US82655M2061 Sify Technologies Ltd. 04.10.2024 Tausch 6:1
MHY8564W1030 Teekay Corp. 03.10.2024 BMG8726T1053 Teekay Corp. 04.10.2024 Tausch 1:1...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
